No Data
No Data
Arcus a New Overweight at Wells Fargo on Potential of Casdatifan in Kidney Cancer
Viking Therapeutics Unusual Options Activity
Nano-Cap Bio-Path Takes Plunge In Weight Loss Race, Initiates Obesity Program With Drug Candidate Under Development For Blood Cancer
In-Depth Examination Of 11 Analyst Recommendations For AbbVie
AbbVie Analyst Ratings
Gilead Upgraded to Overweight by Wells Fargo, PrEP Launch Cited
10baggerbamm : yes support 121 a rally in the stocks will put it about $146 and either could happen within two days of one another because this ETF moves very fast